ArticleLung Cancer (Auckland, N.Z.)2025

Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an

Sai-Hong Ignatius Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.